These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer. Saiers JH; Slavik M Vet Hum Toxicol; 1981; 23(Suppl 1):12-4. PubMed ID: 6272470 [No Abstract] [Full Text] [Related]
28. Cancer treatment today and its impact on drug development, with special emphasis on the phase II clinical trial. Carter SK J Natl Cancer Inst; 1976 Aug; 57(2):235-44. PubMed ID: 794496 [No Abstract] [Full Text] [Related]
29. Chemotherapy of malignant ovarian tumors; therapeutic results of ifosfamide. Yakushiji M; Tsunawaki A; Nishida T; Nishimura H; Natsuaki Y; Inoue T; Kato T Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1071-6. PubMed ID: 7304132 [TBL] [Abstract][Full Text] [Related]
30. [Progress in the chemotherapy of malignant tumors]. Cavalli F Ther Umsch; 1985 Aug; 42(8):541-6. PubMed ID: 3863258 [No Abstract] [Full Text] [Related]
31. [Ifosfamide in the treatment of solid tumors and their metastases]. Wicart L Nouv Presse Med; 1976 Apr; 5(15):996-8. PubMed ID: 778786 [No Abstract] [Full Text] [Related]
33. The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma. McNiel NO; Morgan LR Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):490-3. PubMed ID: 7298241 [TBL] [Abstract][Full Text] [Related]
34. [Clinical studies of ifosfamide for gynecological malignancies]. Kohno I; Kazuta M; Miyao J; Kunimi N; Kawamoto M; Tanimura T; Fujiwara K; Sekiba K Gan To Kagaku Ryoho; 1983 May; 10(5):1278-84. PubMed ID: 6870299 [TBL] [Abstract][Full Text] [Related]
35. [Prevention of urinary tract toxicity of oxazaphosphorines by a "uroprotector". Report on a field study (author's transl)]. Burkert H; Schnitker J; Fichtner E MMW Munch Med Wochenschr; 1979 Jun; 121(22):760-2. PubMed ID: 112422 [TBL] [Abstract][Full Text] [Related]
36. Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer. Buzdar AU; Legha SS; Tashima CK; Yap HY; Hortobagyi GN; Hersh EM; Blumenschein GR; Bodey GP Cancer Treat Rep; 1979 Jan; 63(1):115-20. PubMed ID: 369682 [TBL] [Abstract][Full Text] [Related]
37. Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder. Gad-el-Mawla N; Ziegler JL; Hamza R; Elserafi M; Khaled H Cancer Treat Rep; 1984 Feb; 68(2):419-21. PubMed ID: 6697330 [No Abstract] [Full Text] [Related]
38. Proceedings of a symposium on ifosfamide (Mitoxana; Holoxan) and Mesna (Uromitexan). Coventry, U.K., 16-18 March 1983. Cancer Treat Rev; 1983 Sep; 10 Suppl A():1-192. PubMed ID: 6414687 [No Abstract] [Full Text] [Related]
39. [Cisplatin]. Ogawa M Gan To Kagaku Ryoho; 1984 May; 11(5):1140-6. PubMed ID: 6326687 [No Abstract] [Full Text] [Related]
40. [Evaluation of cancer chemotherapy in primary ovarian cancer in rats--observation of histological effect by light and electron microscopy]. Nishida T; Nishida T; Oda T; Sugiyama T; Iwanaga S; Katabuchi H; Araki T Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):8-12. PubMed ID: 6421965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]